| Critical overview of clinical guidelines relating to invasive fungal infections. | |
| | |
MedLine Citation:
|
PMID: 19013341 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The incidence of invasive fungal infections (IFIs) has continued to grow in recent years. IFIs are associated with significant morbidity and mortality as well as costs. The diagnostic and therapeutic approaches to IFI have changed significantly in recent years, fostered by the introduction of new diagnostic methods and new antifungal products. There are also new therapeutic approaches such as de-escalation, pre-emptive antifungal treatment or combined treatment with antifungals. All of these aspects have been described in many trials, meta-analyses and reviews. There are also different clinical guidelines for IFIs with diagnostic and therapeutic recommendations. They are of unquestionable value and at the same time represent different perspectives on the problem. The lack of homogeneity when selecting and drafting the recommendations is a problem, and some of them are based more on personal opinion than on evidence. In this paper, we have put together a critical overview of the role of guidelines for IFIs, with emphasis on non-neutropenic critical patients. |
| | |
Authors:
|
Márcio Borges Sá; Rafael Zaragoza |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: International journal of antimicrobial agents Volume: 32 Suppl 2 ISSN: 0924-8579 ISO Abbreviation: Int. J. Antimicrob. Agents Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-11-17 Completed Date: 2009-02-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9111860 Medline TA: Int J Antimicrob Agents Country: Netherlands |
Other Details:
|
Languages: eng Pagination: S155-9 Citation Subset: IM |
Affiliation:
|
Servicio de Medicina Intensiva, Hospital Son Llàtzer, Carretera de Manacor, Palma de Mallorca, Spain. mborges@hsll.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Guidelines as Topic* Humans Mycoses / diagnosis*, drug therapy*, prevention & control |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recip...
Next Document: Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.